Furthermore, increased levels of CCL3, CCL4 and CXCL10 can be identified in the synovial fluid and plasma of RA patients, whereas CCL5 only seems to be elevated in the plasma but reduced in contrast in the synovium of RA patients (67, 161–164). The gene discussed is CXCL10; the disease is rheumatoid arthritis.